Biotechnology Stocks I Performance Guide: ACADIA Pharmaceuticals Inc. (ACAD)
ACAD has no dividends
Table and Chart of ACAD Performance
See what a $1,000 investment in ACAD is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| ACAD Returns | |
|---|---|
| Start Date | Dec-31-2013 |
| Start Price | $24.99 |
| End Date | Dec-01-2023 |
| End Price | $22.60 |
| # Prices | 121 |
| Min Date | Jun-30-2022 |
| Min Price | $14.09 |
| Max Date | Nov-30-2020 |
| Max Price | $56.66 |
| Total Return | -9.56% |
| Annualized Return | -0.99% |
| Current Value of $1,000 Purchase | $904 |
| Number Returns | 7,260 |
| Average Return | 0.85% |
| Number Profitable Returns | 3,033 |
| Percent Profitable Returns | 41.78% |
| Number Unprofitable Returns | 4,227 |
| Percent Unprofitable Returns | 58.22% |
| Profitable to Unprofitable Returns Ratio | 0.72 |
| ACAD Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $3,712,118,000 | Price to Sales | 5.87 |
| Earnings per Share | $-0.9100 |
| PE Ratio | None |
| PE to Growth Ratio | -0.42 |
| Price to Book | 10.24 |
| PRICE DATA | |
| 52 Week High | $33.99 |
| 52 Week Low | $14.45 |
| Analyst Target Price | $32.75 |
| 50-Day Moving Average | $22.63 |
| 200-Day Moving Average | $23.44 |
| FINANCIAL DATA | |
| Revenue per Share | $3.874 |
| Revenue | $631,886,000 |
| Profit Margin | -23.5% |
| Return on Equity | -0.378% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
ACAD Compare Returns with S&P 500
ACAD Trendline Chart